Results 121 to 130 of about 158,509 (197)

Utility of alternative specimens in the diagnosis of pulmonary tuberculosis in people living with human immunodeficiency virus in Guinea. [PDF]

open access: yesBMC Infect Dis
Diallo BD   +12 more
europepmc   +1 more source

Prevalence and Predictors of Long Covid in a Cohort of Brazilian Adults 12 Months After Acute Infection: A Cross‐Sectional Study

open access: yesHealth Expectations, Volume 28, Issue 6, December 2025.
ABSTRACT Introduction Since the onset of the pandemic in early 2020, various reports have emerged regarding persistent symptoms associated with Covid‐19. Nevertheless, there is insufficient data on the persistence of symptoms over time. This study sought to estimate the prevalence of persistent symptoms 12 months after Covid‐19 infection and identify ...
Eduardo Rocha Covre   +16 more
wiley   +1 more source

Systemic neutrophil activation and N‐formyl methionine‐formyl peptide receptor‐1 signaling define inflammatory endotypes in rheumatoid arthritis‐associated lung involvement

open access: yesJournal of Internal Medicine, Volume 298, Issue 6, Page 656-669, December 2025.
Abstract Background Neutrophil activation plays a crucial role in the pathogenesis of rheumatoid arthritis (RA), but its involvement in RA‐associated interstitial lung disease (RA‐ILD) remains unclear. This study investigated the involvement of N‐formyl methionine (fMET) and its receptor formyl peptide receptor‐1 (FPR1) in neutrophil‐mediated ...
Jia Shi   +14 more
wiley   +1 more source

Neutrophil proteins as potential biomarkers for a sputum-based tuberculosis screening test. [PDF]

open access: yesFront Immunol
Chambers M   +20 more
europepmc   +1 more source

Efficacy, safety and predictive biomarker of third‐generation tyrosine kinase inhibitors with azacitidine in myeloid blast phase of chronic myeloid leukemia

open access: yesCancer, Volume 131, Issue 22, 15 November 2025.
Abstract Objective To evaluate the efficacy, safety, and predictive biomarker of a third‐generation tyrosine kinase inhibitor (3G‐TKI; ponatinib or olverembatinib) combined with azacitidine in chronic myeloid leukemia (CML) in myeloid blast phase. Methods We conducted a single‐center, prospective study combining 3G‐TKI with azacitidine in 28‐day cycles.
Mei Bao   +9 more
wiley   +1 more source

Advanced Nanoparticle Therapeutics for Targeting Neutrophils in Inflammatory Diseases

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 28, November 3, 2025.
This review highlights recent advances in nanoparticle‐based strategies to modulate neutrophil activity in inflammatory diseases. By targeting inflammatory neutrophils, NET formation, and neutrophil apoptosis or recruitment, these approaches aim to improve therapeutic precision.
Min Ji Byun   +9 more
wiley   +1 more source

Impact of Intraoperative Fluid Volume on Complications After Minimally Invasive Esophagectomy: Analysis of 8782 Patients From the Japanese National Clinical Database

open access: yesAnnals of Gastroenterological Surgery, Volume 9, Issue 6, Page 1199-1206, November 2025.
This multicenter cohort study of 8782 esophagectomies in Japan found that higher intraoperative fluid volume significantly increased the risk of pneumonia after minimally invasive esophagectomy. Avoiding fluid overload may help reduce postoperative pneumonia.
Akihiko Okamura   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy